14 min readSep 24, 2026 06:30 AM IST First published on: Sep 24, 2026 at 06:30 AM ISTSai Life Sciences had a breakout year. Revenue grew strongly, but profits grew even faster, more than doubling in FY26. The momentum hasn’t slowed down, with Q1 FY27 continuing to show double-digit growth across revenue and profitability.At around Rs 1,584 per share, Sai’s market capitalisation is approximately Rs 33,650 crore, and the trailing P/E is above 90x.